they have enough cash in the bank to get through stage one.
I think that it would be a shame to see Dr Melroses work get thrown aside by big pharma, and I believe the current staff feel the same way - especially James Graham. No chance they will sell out the IP. And with so many potential revenue streams, and with sepsis such a huge killer globally, I could easily see big pharma trying to work with recce instead
I would like to know how much volume the current production plant in Sydney can produce. I imagine it would be easy to set one up in the US if we work with big pharma there
Ann: Recce Adds Biotech Veteran Alan W. Dunton M.D. to its Board, page-53
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13550 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 18938 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |